A role for mitochondrial oxidants in stress-induced premature senescence of human vascular smooth muscle cells

Redox Biology

Volumn 1, Issue 1, 2013, Pages 411-417

  Mistry, Yogita ^a   Poolman, Toryn ^a   Williams, Bryan ^a   Herbert, Karl E ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Angiotensin II; Cell senescence; Mitochondria; Stress induced premature senescence; Superoxide; Vascular smooth muscle cell

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; LUCIGENIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ROTENONE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TEMPOL; ANGIOTENSIN RECEPTOR;

ARTICLE; CELL AGING; CELL LYSATE; CHEMOLUMINESCENCE; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRION; MOLECULAR INTERACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; METABOLISM;

ANGIOTENSIN II; CELL AGING; CELLS, CULTURED; HUMANS; MITOCHONDRIA; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NADPH OXIDASE; OXIDATIVE STRESS; RECEPTORS, ANGIOTENSIN; ROTENONE; SUPEROXIDES;

EID: 84883705230     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2013.08.004     Document Type: Article

References (34)

1. Tchkonia T., Zhu Y., van Deursen J., Campisi J., Kirkland J.L. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. Journal of Clinical Investigation 2013, 123:966-972.
2. Toussaint O., Medrano E.E., von Zglinicki T. Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes. Experimental Gerontology 2000, 35:927-945.
3. Dumont P., Burton M., Chen Q.M., Gonos E.S., Frippiat C., Mazarati J.B., Eliaers F., Remacle J., Toussaint O. Induction of replicative senescence biomarkers by sublethal oxidative stresses in normal human fibroblast. Free Radical Biology & Medicine 2000, 28:361-373.
4. Goligorsky M.S., Chen J., Patschan S. Stress-induced premature senescence of endothelial cells: a perilous state between recovery and point of no return. Current Opinion in Hematology 2009, 16:215-219.
5. Herbert K.E., Mistry Y., Hastings R., Poolman T., Niklason L., Williams B. Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways. Circulation Research 2008, 102:201-208.
6. Martin-Pardillos A., Sosa C., Sorribas V. Arsenic increases Pi-mediated vascular calcification and induces premature senescence in vascular smooth muscle cells. Toxicological Sciences 2013, 131:641-653.
7. Jimenez R., Carracedo J., Santamaria R., Soriano S., Madueno J.A., Ramirez R., Rodriguez M., Martin-Malo A., Aljama P. Replicative senescence in patients with chronic kidney failure. Kidney International Supplements 2005, 99:S11-5.
8. Carracedo J., Buendia P., Merino A., Soriano S., Esquivias E., Martin-Malo A., Aljama P., Ramirez R. Cellular senescence determines endothelial cell damage induced by uremia. Experimental Gerontology 2013, 48:766-773.
9. Minamino T., Miyauchi H., Yoshida T., Ishida Y., Yoshida H., Komuro I. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 2002, 105:1541-1544.
10. Passos J.F., Saretzki G., von Zglinicki T. DNA damage in telomeres and mitochondria during cellular senescence: Is there a connection?. Nucleic Acids Research 2007, 35:7505-7513.
11. Gomez-Cabrera M.C., Sanchis-Gomar F., Garcia-Valles R., Pareja-Galeano H., Gambini J., Borras C., Vina J. Mitochondria as sources and targets of damage in cellular aging. Clinical Chemistry and Laboratory Medicine 2012, 50:1287-1295.
12. Nazarewicz R.R., Dikalova A., Bikineyeva A., Ivanov S., Kirilyuk I.A., Grigor'ev I.A., Dikalov S.I. Does scavenging of mitochondrial superoxide attenuate cancer prosurvival signaling pathways?. Antioxidants & Redox Signaling 2013, 19:344-349.
13. Kunieda T., Minamino T., Nishi J., Tateno K., Oyama T., Katsuno T., Miyauchi H., Orimo M., Okada S., Takamura M., Nagai T., Kaneko S., Komuro I. Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway. Circulation 2006, 114:953-960.
14. Griendling K.K., Minieri C.A., Ollerenshaw J.D., Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circulation Research 1994, 74:1141-1148.
15. Touyz R.M., Chen X., Tabet F., Yao G., He G., Quinn M.T., Pagano P.J., Schiffrin E.L. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circulation Research 2002, 90:1205-1213.
16. de Cavanagh E.M., Inserra F., Ferder L. Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?. Cardiovascular Research 2011, 89:31-40.
17. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proceedings of the National Academy of Sciences USA 1995, 92:9363-9367.
18. Chainiaux F., Magalhaes J.P., Eliaers F., Remacle J., Toussaint O. UVB-induced premature senescence of human diploid skin fibroblasts. International Journal of Biochemistry & Cell Biology 2002, 34:1331-1339.
19. Ben-Porath I., Weinberg R.A. The signals and pathways activating cellular senescence. International Journal of Biochemistry & Cell Biology 2005, 37:961-976.
20. Touyz R.M., Schiffrin E.L. Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. Journal of Hypertension 2001, 19:1245-1254.
21. Murphy M.P., Smith R.A. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annual Review of Pharmacology and Toxicology 2007, 47:629-656.
22. Dikalova A.E., Bikineyeva A.T., Budzyn K., Nazarewicz R.R., McCann L., Lewis W., Harrison D.G., Dikalov S.I. Therapeutic targeting of mitochondrial superoxide in hypertension. Circulation Research 2010, 107:106-116.
23. Hamanaka R.B., Chandel N.S. Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends in Biochemical Sciences 2010, 35:505-513.
24. Murphy M.P. How mitochondria produce reactive oxygen species. Biochemical Journal 2009, 417:1-13.
25. Lassegue B., Sorescu D., Szocs K., Yin Q., Akers M., Zhang Y., Grant S.L. Lambeth JD, Griendling KK. Novel gp91(phox) homologues in vascular smooth muscle cells: Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circulation Research 2001, 88:888-894.
26. Mehta P.K., Griendling K.K. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. American Journal of Physiology-Cell Physiology 2007, 292:C82-97.
27. Doughan A.K., Harrison D.G., Dikalov S.I. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circulation Research 2008, 102:488-496.
28. Queliconi B.B., Wojtovich A.P., Nadtochiy S.M., Kowaltowski A.J., Brookes P.S. Redox regulation of the mitochondrial K(ATP) channel in cardioprotection. Biochimica et Biophysica Acta 2011, 1813:1309-1315.
29. Wosniak J., Santos C.X., Kowaltowski A.J., Laurindo F.R. Cross-talk between mitochondria and NADPH oxidase: effects of mild mitochondrial dysfunction on angiotensin II-mediated increase in nox isoform expression and activity in vascular smooth muscle cells. Antioxidants & Redox Signaling 2009, 11:1265-1278.
30. Dikalov S. Cross talk between mitochondria and NADPH oxidases. Free Radical Biology & Medicine 2011, 51:1289-1301.
31. Smith R.A., Hartley R.C., Cocheme H.M., Murphy M.P. Mitochondrial pharmacology. Trends in Pharmacological Sciences 2012, 33:341-352.
32. Min L.J., Mogi M., Iwai M., Horiuchi M. Signaling mechanisms of angiotensin II in regulating vascular senescence. Ageing Research Reviews 2009, 8:113-121.
33. de Cavanagh E.M., Ferder M., Inserra F., Ferder L. Angiotensin II, mitochondria, cytoskeletal, and extracellular matrix connections: an integrating viewpoint. American Journal of Physiology. Heart and Circulatory Physiology 2009, 296:H550-8.
34. Ferder L., Inserra F., Romano L., Ercole L., Pszenny V. Effects of angiotensin-converting enzyme inhibition on mitochondrial number in the aging mouse. American Journal of Physiology 1993, 265:C15-8.